Search

Amy Lasek Phones & Addresses

  • Richmond, VA
  • 1803 N Cleveland Ave APT 3, Chicago, IL 60614
  • 1812 Dwight Cres, Berkeley, CA 94703 (510) 649-1575
  • Kensington, CA
  • Oakland, CA
  • Alameda, CA
  • New York, NY

Resumes

Resumes

Amy Lasek Photo 1

Associate Professor

View page
Location:
1803 north Cleveland Ave, Chicago, IL 60614
Industry:
Research
Work:
University of Illinois at Chicago
Associate Professor

University of Illinois at Chicago Jul 2012 - Aug 2018
Assistant Professor

Ernest Gallo Clinic and Research Center May 2011 - Jul 2012
Associate Investigator

Ernest Gallo Clinic and Research Center Aug 2003 - Apr 2011
Senior Research Scientist

Incyte Genomics 2000 - 2003
Senior Research Scientist
Education:
Cornell University 1992 - 1998
Doctorates, Doctor of Philosophy, Molecular Biology, Philosophy
Case Western Reserve University 1988 - 1992
Bachelors, Biology, Biochemistry
Skills:
Cell Biology
Animal Models
Molecular Biology
Neuroscience
Immunohistochemistry
Cell Culture
Behavioral Neuroscience
In Vivo
Immunofluorescence
Lifesciences
Scientific Writing
Confocal Microscopy
Western Blotting
Fluorescence Microscopy
Biochemistry
In Vitro
Qpcr
Pcr
Translational Research
Life Sciences
Amy Lasek Photo 2

Amy Lasek

View page

Publications

Us Patents

Genes Expressed In Colon Cancer

View page
US Patent:
20020160382, Oct 31, 2002
Filed:
Oct 11, 2001
Appl. No.:
09/981353
Inventors:
Amy Lasek - Oakland CA, US
David Jones - Salt Lake City UT, US
International Classification:
C12Q001/68
G01N033/574
C07H021/04
C12P021/04
C12N009/00
US Classification:
435/006000, 435/007230, 435/070210, 435/069100, 435/183000, 536/023200
Abstract:
The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in colon cancer, or in a precancerous condition of the colon and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the treatment of a subject with a colon cancer.

Genes Regulated By Dna Methylation In Colon Tumors

View page
US Patent:
20030013099, Jan 16, 2003
Filed:
Mar 7, 2002
Appl. No.:
10/093766
Inventors:
Amy Lasek - Oakland CA, US
David Jones - Salt Lake City UT, US
Adam Karpf - Salt Lake City UT, US
International Classification:
C12Q001/68
G01N033/574
C07H021/04
US Classification:
435/006000, 536/023200, 435/007230
Abstract:
The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed by DNA methylation in tumor cells and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with a disorder such as cancer.

Genes Expressed In Lung Cancer

View page
US Patent:
20030065157, Apr 3, 2003
Filed:
Apr 4, 2002
Appl. No.:
10/116802
Inventors:
Amy Lasek - Oakland CA, US
International Classification:
C07H021/02
C07H021/04
US Classification:
536/023100
Abstract:
The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in a respiratory disorder and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with a respiratory disorder.

Transmembrane Protein Differentially Expressed In Cancer

View page
US Patent:
20030068311, Apr 10, 2003
Filed:
Jul 1, 2002
Appl. No.:
10/187657
Inventors:
Amy Lasek - Oakland CA, US
Mariah Baughn - San Leandro CA, US
Yalda Azimzai - Oakland CA, US
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
A61K038/43
C12Q001/68
C07H021/04
C12N009/00
C12P021/02
C12N005/06
US Classification:
424/094100, 435/069100, 435/183000, 435/325000, 435/320100, 536/023200, 435/006000
Abstract:
The invention provides a transmembrane protein that is differentially expressed in neoplastic disorders. It also provides for the use of the protein, a cDNA encoding the protein, and antibodies that specifically bind the protein in various methods to diagnose, stage, treat, or monitor the treatment of a neoplastic disorder.

Genes Expressed In Colon Cancer

View page
US Patent:
20030073105, Apr 17, 2003
Filed:
May 29, 2002
Appl. No.:
10/158646
Inventors:
Amy Lasek - Oakland CA, US
Thierry Sornasse - Mountain View CA, US
International Classification:
C12Q001/68
G01N033/574
C07H021/04
US Classification:
435/006000, 435/007230, 536/023200
Abstract:
The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in colon cancer and which may be used in their entirety or in part as to diagnose, to stage to treat or to monitor the progression or treatment of colon cancer.

Colon Cancer Marker

View page
US Patent:
20030082603, May 1, 2003
Filed:
Aug 29, 2002
Appl. No.:
10/232803
Inventors:
Amy Lasek - Oakland CA, US
Randi Krasnow - Stanford CA, US
Bridget Warren - Encinitas CA, US
Mariah Baughn - San Leandro CA, US
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
C12Q001/68
G01N033/574
C07H021/04
C12N009/00
C12M001/34
C12P021/02
C12N005/06
US Classification:
435/006000, 435/069100, 435/007230, 435/183000, 435/320100, 435/325000, 435/287200, 536/023200
Abstract:
The invention provides a cDNA which encodes a colon cancer marker. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of colon disorders, particularly colon cancer and polyps. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.

Genes Regulated By Dna Methylation In Tumor Cells

View page
US Patent:
20030165864, Sep 4, 2003
Filed:
Jan 16, 2002
Appl. No.:
10/051835
Inventors:
Amy Lasek - Oakland CA, US
David Jones - Salt Lake City UT, US
International Classification:
C12Q001/68
C07H021/04
C12N009/10
C12P021/02
C12N005/06
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 435/193000, 536/023200
Abstract:
The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed by DNA methylation in tumor cells and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with a disorder such as cancer.

Genes Expressed In Lung Cancer

View page
US Patent:
20030175704, Sep 18, 2003
Filed:
Oct 4, 2001
Appl. No.:
09/971429
Inventors:
Amy Lasek - Oakland CA, US
Andrew Shyjan - San Carlos CA, US
Christopher Turner - Stanford CA, US
International Classification:
C12Q001/68
C07H021/04
US Classification:
435/006000, 536/023200
Abstract:
The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in respiratory disorders and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with a respiratory disorder including lung cancer, chronic obstructive pulmonary disease, emphysema, and asthma.
Amy Wolven Lasek from Richmond, VA, age ~55 Get Report